Corebridge Financial Files Definitive Proxy for All-Stock Merger with Equitable Holdings
Summary
Corebridge Financial has filed its definitive proxy statement for the all-stock merger with Equitable Holdings, setting the stage for a shareholder vote on July 30, 2026, on the creation of a new financial services leader.
Key Events
-
Merger Agreement Details
Corebridge shareholders will receive 1.000 shares of New Equitable Common Stock for each Corebridge share, while Equitable shareholders will receive 1.55516 shares for each Equitable share. Corebridge shareholders are expected to own approximately 51% of the combined company.
-
Shareholder Vote Scheduled
Special meetings for both Corebridge and Equitable shareholders are set for July 30, 2026, to vote on the merger agreement and related proposals, including an Employee Stock Purchase Plan and advisory compensation.
-
Strategic Rationale & Synergies
The merger aims to create a leading retirement, life, wealth, and asset management platform, with an estimated $500 million in annual expense synergies by the third year post-closing and expected double-digit EPS and cash generation accretion by 2028.
-
Governance Structure
The new entity, 'New Equitable' (to be renamed Equitable Holdings, Inc.), will have a 14-member board with equal representation from both companies. Corebridge's CEO will become the President and CEO of New Equitable, and Equitable's CEO will serve as Executive Chair. Headquarters will be in Houston, Texas.
Analysis
This filing provides the definitive proxy statement for the previously announced all-stock merger between Corebridge Financial and Equitable Holdings. Shareholders will vote on July 30, 2026, on the merger agreement, which outlines fixed exchange ratios, a 51% ownership for Corebridge shareholders in the combined entity, and a new governance structure. The combined company is expected to achieve $500 million in annual expense synergies and double-digit EPS and cash generation accretion by 2028, creating a leading financial services platform.
At the time of this filing, CRBG was trading at $28.91 on NYSE in the Finance sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $22.19 to $36.57. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.